Increase of serum and membrane-bound angiotensin-converting enzyme by captopril (SQ 14225) treatment.
D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D002216:Captopril / Q000627:therapeutic use*; D002462:Cell Membrane / Q000201:enzymology; D002478:Cells, Cultured; D004727:Endothelium / Q000166:cytology; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008168:Lung / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism*; D011392:Proline / Q000031:analogs & derivatives*; D051381:Rats; D011919:Rats, Inbred Strains; D013268:Stimulation, Chemical
D000806:Angiotensin-Converting Enzyme Inhibitors; D011392:Proline; D002216:Captopril; D007703:Peptidyl-Dipeptidase A